
Loading, please wait...

Loading, please wait...

Recent breakthroughs in Glabridin synthesis have paved the way for advanced dermatological and pharmaceutical applications. Glabridin is a major isoflavane found in licorice (Glycyrrhiza glabra). It is highly valued for its potent antioxidant, anti-inflammatory, and skin-whitening properties. However, extracting pure Glabridin from natural sources remains difficult and costly due to its low concentration in roots.
Researchers recently described a modular, stereodivergent chemoenzymatic strategy to produce both enantiomers of this compound. This Glabridin synthesis approach utilizes a lipase-catalyzed dynamic kinetic resolution. This specific step establishes the critical benzylic stereocenter while preserving stereochemical integrity. Consequently, the team successfully delivered (-)-glabridin in 10 steps with a 14% overall yield. Additionally, they produced (+)-glabridin in 12 steps with a 7% yield. Notably, using inexpensive, resorcinol-derived building blocks makes this platform commercially viable.
In India, licorice—known as Yashtimadhu—is a cornerstone of AYUSH practices. Traditionally, practitioners use it to treat hyperpigmentation and inflammatory skin conditions. This synthetic breakthrough provides a reliable supply of high-purity Glabridin. Furthermore, it allows researchers to investigate the distinct biological activities of each enantiomer. Most current dermatological formulations rely on racemic mixtures or crude extracts. However, the ability to synthesize specific enantiomers could lead to more targeted and effective treatments for melasma and photo-aging.
Glabridin inhibits tyrosinase activity, which is the primary enzyme responsible for melanin production. This process effectively reduces hyperpigmentation and evens out skin tone without the irritation often caused by chemical lighteners.
Chemoenzymatic methods combine the precision of biological catalysts with the flexibility of organic chemistry. This allows for higher stereoselectivity and more sustainable production of complex natural molecules.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional judgment. Always consult with a qualified healthcare provider for specific medical concerns. Refer to the latest local and national guidelines for clinical practice.
References
Wang X et al. Modular Stereodivergent Chemoenzymatic Total Synthesis of (+)- and (-)-Glabridin. Chemistry. 2026 Mar 26. doi: 10.1002/chem.70931. PMID: 41888064.
Yokota T et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11(6):355-361.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a modular chemoenzymatic strategy to synthesize both enantiomers of Glabridin, a key natural product used in dermatology and AYUS...
5 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today